Clinical Trials List
2013-02-01 - 2021-12-31
Phase III
Terminated4
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jin-Hou Wu Division of Hematology & Oncology
- 洪玉馨 Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
- 高小雯 Division of Hematology & Oncology
- Po-Nan Wang Division of Hematology & Oncology
- 湯崇志 Division of Hematology & Oncology
- 鄧 波 Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
- Hung Chang 未分科
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Yu-Min Liao Division of Hematology & Oncology
- 林柏翰 Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
300 participants
